CNL and aCML should be considered as a single entity based on molecular profiles and outcomesGonzalo Carreño‐Tarragona, Nicholas C.P. Cross, José Carlos Martínez Ávila et al.|Blood Advances|2023Cited by 32
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of MyelofibrosisAdrián Mosquera-Orgueira, Manuel Pérez‐Encinas, Alberto Hernández‐Sánchez et al.|HemaSphere|2022Cited by 30